Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations
Year: 2017
Type: review
Abstract: -methyl-d-aspartate (NMDA) receptors causes neurodegeneration and cell death. The disease mechanism involves a pathological triad consisting of mitochondrial dysfunction, loss of integrity of neuronal structures and connectivity, and disruption of excitation-transcription coupling caused by CREB (cyclic adenosine monophosphate-responsive element-binding protein) shut-off and nuclear accumulation of class IIa histone deacetylases. Interdependency within the triad fuels an accelerating disease progression that culminates in failure of mitochondrial energy production and cell loss. Both acute and slowly progressive neurodegenerative conditions, including stroke, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease, share increased death signaling by extrasynaptic NMDA receptors caused by elevated extracellular glutamate concentrations or relocalization of NMDA receptors to extrasynaptic sites. Six areas of therapeutic objectives are defined, based on which a broadly applicable combination therapy is proposed to combat the pathological triad of extrasynaptic NMDA receptor signaling that is common to many neurodegenerative diseases.
DOI: 10.1084/jem.20161673
Author: Hilmar Bading
Institution: Heidelberg University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: extrasynaptic NMDA receptors, neurodegeneration, mitochondrial dysfunction, CREB, class IIa histone deacetylases, excitation-transcription coupling, glutamate excitotoxicity, stroke, Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, combination therapy, neuronal cell death
Open Access status: hybrid
OpenAlex ID: W2587852248
